Health Care & Life Sciences » Biotechnology | Catabasis Pharmaceuticals Inc.

Catabasis Pharmaceuticals Inc. | Ownership

Companies that own Catabasis Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Federated Global Investment Management Corp.
10,434,000
14.69%
10,434,000
0.05%
06/30/2018
Empery Asset Management LP
5,000,000
7.04%
5,000,000
4.29%
06/20/2018
Heights Capital Management, Inc.
2,680,752
3.77%
2,680,752
0.05%
06/30/2018
The Vanguard Group, Inc.
2,519,315
3.55%
1,934,600
0%
06/30/2018
Stonepine Capital Management LLC
2,400,000
3.38%
2,400,000
0.98%
06/30/2018
Armistice Capital LLC
2,000,000
2.82%
2,000,000
0.11%
06/30/2018
Corriente Advisors LLC
1,692,899
2.38%
1,692,899
100%
02/16/2018
Alyeska Investment Group LP
1,121,505
1.58%
1,003,887
0.01%
06/30/2018
Renaissance Technologies LLC
834,900
1.18%
-117,300
0%
06/30/2018
Millennium Management LLC
530,187
0.75%
530,187
0%
06/30/2018

About Catabasis Pharmaceuticals

View Profile
Address
One Kendall Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.catabasis.com
Updated 07/08/2019
Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of therapeutics for the treatment of cardiovascular, metabolic and inflammatory diseases. The company was founded by Jill C.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.